A new study has shown that a cancer-killing (‘oncolytic’) virus currently in clinical trials may function as a cancer vaccine — in addition to killing some cancer cells directly, the virus alerts the immune system to the presence of a tumor, triggering a powerful, widespread immune response that kills cancer cells far outside the virus-infected region.

https://www.sciencedaily.com/releases/2018/02/180213145826.htm